Bellevue Group AG - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$29,305,177
+27.8%
241,752
+20.7%
0.47%
+44.3%
Q2 2023$22,929,195
-74.3%
200,220
-69.0%
0.33%
-74.7%
Q1 2023$89,122,808
-0.8%
646,614
-6.7%
1.29%
+8.5%
Q4 2022$89,826,022
+7.5%
693,209
-8.3%
1.19%
-0.6%
Q3 2022$83,557,000
-2.2%
755,898
-33.7%
1.20%
-0.7%
Q2 2022$85,414,000
-5.0%
1,139,455
-1.0%
1.21%
+15.6%
Q1 2022$89,929,000
+20.8%
1,151,159
+39.2%
1.04%
+36.1%
Q4 2021$74,448,000
+41.4%
826,741
+45.3%
0.77%
+43.6%
Q3 2021$52,637,000
+3379.0%
569,168
+2703.8%
0.53%
+3237.5%
Q1 2021$1,513,000
-56.3%
20,3000.0%0.02%
-60.0%
Q4 2020$3,461,000
+21.4%
20,3000.0%0.04%
+2.6%
Q3 2020$2,851,000
-12.4%
20,3000.0%0.04%
-15.2%
Q2 2020$3,255,000
+66.4%
20,300
+1.5%
0.05%
+21.1%
Q1 2020$1,956,000
-2.2%
20,000
+29.0%
0.04%
+18.8%
Q4 2019$2,000,000
+84.3%
15,500
+70.3%
0.03%
-46.7%
Q1 2019$1,085,000
-21.7%
9,100
-28.3%
0.06%
-34.1%
Q4 2018$1,386,000
-34.5%
12,700
-3.1%
0.09%
-32.1%
Q3 2018$2,116,00013,1000.13%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders